Tam S P, Lam K S, Srivastava G
Department of Medicine, University of Hong Kong, Hong Kong.
Endocrinology. 1996 Feb;137(2):418-24. doi: 10.1210/endo.137.2.8593784.
Thyroid hormones are important to growth in mammals and have been shown to rapidly stimulate the rate of GH gene transcription. In this study, we investigated whether thyroid hormones modulate GH secretion through their effects on the gene expression of GRF, somatostatin (SS), GRF receptor, and receptor subtype 2 for SS (SSTR2). Male adult Sprague-Dawley rats were rendered hypothyroid with a single injection of propylthiouracil followed by methimazole in drinking water (0.02%) for 1 day to 12 weeks. Total RNA extracted from the anterior pituitary and hypothalamus was analyzed by Northern hybridization. GH messenger RNA (mRNA) level in the anterior pituitary was significantly reduced in the hypothyroid animals (P < 0.0001 vs. controls for all treatment duration > or = 1 week). An increase in hypothalamic GRF mRNA level, by 2- and 4-fold, respectively, was seen after 3 and 12 weeks of antithyroid treatment (both P < 0.001 vs. controls). Hypothalamic GRF content, studied in 12-week hypothyroid rats only, was decreased compared with controls (P < 0.05). A reduction in pituitary GRF receptor mRNA level was observed after 1 week of antithyroid treatment (P < 0.01 after 1 week, P < 0.001 after 3 weeks). Total hypothalamic SS content and SS mRNA level in hypothalamic fragments consisting predominantly of the paraventricular and periventricular nuclei became significantly decreased (P < 0.05 and P < 0.005 respectively) after 12-weeks of antithyroid treatment. The reduction in SS gene expression in the periventricular nuclei was confirmed by in situ hybridization. No significant change in the mRNA level of pituitary SSTR2 was observed up to 12 weeks of antithyroid treatment. In conclusion, we have demonstrated a reduction in the gene expression of GRF receptor and SS in the hypothyroid rat. Our results suggest that the changes in hypothalamic GRF and SS gene expression in hypothyroid rats may be compensatory in nature and are likely to be secondary to the reduction in GH synthesis and secretion in these animals. The reduction in basal and GRF-stimulated GH secretion in hypothyroidism can be explained by the observed reduction in GH and GRF receptor gene expression.
甲状腺激素对哺乳动物的生长很重要,并且已被证明能迅速刺激生长激素(GH)基因的转录速率。在本研究中,我们调查了甲状腺激素是否通过影响生长激素释放因子(GRF)、生长抑素(SS)、GRF受体以及SS受体亚型2(SSTR2)的基因表达来调节GH分泌。成年雄性Sprague-Dawley大鼠通过单次注射丙硫氧嘧啶,随后饮用含甲巯咪唑(0.02%)的水1天至12周,从而造成甲状腺功能减退。通过Northern杂交分析从垂体前叶和下丘脑提取的总RNA。甲状腺功能减退的动物垂体前叶中生长激素信使核糖核酸(mRNA)水平显著降低(所有治疗持续时间≥1周时,与对照组相比P<0.0001)。抗甲状腺治疗3周和12周后,下丘脑GRF mRNA水平分别升高2倍和4倍(两者与对照组相比P<0.001)。仅在12周甲状腺功能减退大鼠中研究的下丘脑GRF含量与对照组相比降低(P<0.05)。抗甲状腺治疗1周后观察到垂体GRF受体mRNA水平降低(1周后P<0.01,3周后P<0.001)。抗甲状腺治疗12周后,主要由室旁核和室周核组成的下丘脑片段中的下丘脑总SS含量和SS mRNA水平显著降低(分别为P<0.05和P<0.005)。通过原位杂交证实了室周核中SS基因表达的降低。直至抗甲状腺治疗12周,垂体SSTR2的mRNA水平未观察到显著变化。总之,我们已经证明甲状腺功能减退大鼠中GRF受体和SS的基因表达降低。我们的结果表明,甲状腺功能减退大鼠下丘脑GRF和SS基因表达的变化可能本质上是代偿性的,并且很可能继发于这些动物中GH合成和分泌的减少。甲状腺功能减退时基础和GRF刺激的GH分泌减少可以通过观察到的GH和GRF受体基因表达降低来解释。